Michael A. Schlesinger - 11 Aug 2021 Form 4 Insider Report for Ortho Clinical Diagnostics Holdings plc

Role
EVP, GC and Secretary
Signature
/s/ Michael A. Schlesinger
Issuer symbol
N/A
Transactions as of
11 Aug 2021
Net transactions value
-$1,148,921
Form type
4
Filing time
13 Aug 2021, 17:22:45 UTC
Next filing
18 Aug 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OCDX Ordinary Shares, $0.00001 par value Options Exercise $455,834 +72,585 +83% $6.28 160,222 11 Aug 2021 Direct
transaction OCDX Ordinary Shares, $0.00001 par value Sale $1,434,621 -72,585 -45% $19.76 87,637 11 Aug 2021 Direct F1, F2, F3
transaction OCDX Ordinary Shares, $0.00001 par value Options Exercise $50,868 +8,100 +9.2% $6.28 95,737 12 Aug 2021 Direct
transaction OCDX Ordinary Shares, $0.00001 par value Sale $162,003 -8,100 -8.5% $20.00 87,637 12 Aug 2021 Direct F1, F2, F4
transaction OCDX Ordinary Shares, $0.00001 par value Options Exercise $27,004 +4,300 +4.9% $6.28 91,937 13 Aug 2021 Direct
transaction OCDX Ordinary Shares, $0.00001 par value Sale $86,003 -4,300 -4.7% $20.00 87,637 13 Aug 2021 Direct F1, F2, F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OCDX Stock Option Options Exercise $0 -72,585 -17% $0.000000 350,922 11 Aug 2021 Ordinary Shares, $0.00001 par value 72,585 $6.28 Direct F6
transaction OCDX Stock Option Options Exercise $0 -8,100 -2.3% $0.000000 342,822 12 Aug 2021 Ordinary Shares, $0.00001 par value 8,100 $6.28 Direct F6
transaction OCDX Stock Option Options Exercise $0 -4,300 -1.3% $0.000000 338,522 13 Aug 2021 Ordinary Shares, $0.00001 par value 4,300 $6.28 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2 The Reporting Person undertakes to provide, upon request by the Securities Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported in this Form 4.
F3 Represents the weighted average sales price for the price increments ranging from $19.4800 to $20.0700.
F4 Represents the weighted average sales price for the price increments ranging from $20.0000 to $20.0050.
F5 Represents the weighted average sales price for the price increments ranging from $20.0000 to $20.0100.
F6 The stock option is fully vested and exercisable.